Trial Profile
Clinical Study of GPC3-targeted Autologous T Cells in Patients with Relapsed or Refractory Lung Cancer, Gastric Carcinoma and Breast Cancer
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Nov 2016
Price :
$35
*
At a glance
- Drugs GPC3-CAR-T (Primary)
- Indications Breast cancer; Gastric cancer; Lung cancer
- Focus Adverse reactions; Pharmacokinetics
- 24 Nov 2016 New trial record